Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996
Autore:
Ouellet, LJ; Thorpe, LE; Hue, DZ; Bailey, SL; Jimenez, AD; Johnson, WA; Rahimian, A; Monterroso, E;
Indirizzi:
Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60612 USA Univ Illinois Chicago IL USA 60612 emiol & Biostat, Chicago, IL 60612 USA Emory Univ, Sch Med, Dept Family & Prevent Med, Atlanta, GA USA Emory Univ Atlanta GA USA ed, Dept Family & Prevent Med, Atlanta, GA USA Ctr Dis Control & Prevent, Atlanta, GA USA Ctr Dis Control & Prevent Atlanta GA USA trol & Prevent, Atlanta, GA USA
Titolo Testata:
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
fascicolo: 5, volume: 25, anno: 2000,
pagine: 443 - 450
SICI:
1525-4135(200012)25:5<443:PAIOHA>2.0.ZU;2-S
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; ENTERING METHADONE TREATMENT; AIDS RISK BEHAVIORS; OUTREACH PROGRAM; NATIONAL SAMPLE; UNITED-STATES; INFECTION; SEROPREVALENCE; POPULATIONS;
Keywords:
adult; Chicago/epidemiology; female; human; HIV seropositivity/epidemiology; incidence; male; prevalence studies; risk factors; substance abuse; intravenous/complications;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
55
Recensione:
Indirizzi per estratti:
Indirizzo: Ouellet, LJ Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, 2121 W Taylor, Chicago, IL 60612 USA Univ Illinois 2121 W Taylor Chicago IL USA 60612 IL 60612 USA
Citazione:
L.J. Ouellet et al., "Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996", J ACQ IMM D, 25(5), 2000, pp. 443-450

Abstract

Objectives: To assess HIV prevalence, incidence, and associated risk factors among IDUs in Chicago,Methods: Seven hundred ninety-four street-recruited IDUs ranging in age from 18 to 50 years, who were not in drug treatment at study enrollment, wereinterviewed and tested for HIV at baseline and at two follow-ups scheduled6 and 12 months after baseline. Questionnaires assessed respondents' demographic characteristics, medical and drug treatment histories, drug use, andsexual practices. Results: HIV seroprevalence at baseline was 18%. Logistic regression identified the following determinants of prevalent HIV infection: Puerto Rican ethnicity, homosexual or bisexual self-identification, injecting for 4 or more years, and having smoked crack cocaine in the past 6 months. Follow-up data were collected from 584 (73.6%) participants. Mean duration of follow-up was 16.5 months, indicating that most subjects had follow-up intervals longer than the scheduled 6 and 12 months, Seven HIV seroconversions were observed in 632 person years of risk, yielding an incidence rate of 1.1 per 100 person years of risk. Injection for 3 or less years was positively associated with HIV seroconversion. Conclusions: The findings provide evidence of a decline in HIV incidence among IDUs, though newer injectors remain at elevated risk for infection.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/04/20 alle ore 20:51:05